Name | ML290 |
---|---|
Synonyms |
MFCD28118984
Benzamide, 2-(1-methylethoxy)-N-[2-[[[3-[(trifluoromethyl)sulfonyl]phenyl]amino]carbonyl]phenyl]- 2-Isopropoxy-N-[2-({3-[(trifluoromethyl)sulfonyl]phenyl}carbamoyl)phenyl]benzamide ML290 ML-290 |
Description | ML-290 is a potent and orally active relaxin/insulin-like family peptide receptor (RXFP1) agonist and activator of anti-fibrotic genes, with an EC50 of 94 nM[1]. |
---|---|
Related Catalog | |
Target |
EC50: 94 nM (RXFP1)[1] |
In Vitro | ML-290 is a potent and orally active relaxin/insulin-like family peptide receptor (RXFP1) agonist and activator of anti-fibrotic genes, with an EC50 of 94 nM[1]. ML290 (5 μM) shows anti-fibrotic, relaxin-like gene expression at 24 and 72 h in activated human hepatic stellate cells[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 523.5±50.0 °C at 760 mmHg |
Molecular Formula | C24H21F3N2O5S |
Molecular Weight | 506.49 |
Flash Point | 270.4±30.1 °C |
Exact Mass | 506.112335 |
LogP | 5.00 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.590 |
Storage condition | 2-8℃ |
RIDADR | NONH for all modes of transport |
---|